Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02941718 · ClinicalTrials.gov registry record · Phase 3
Examination of Sleep, Smoking Cessation, and Cardiovascular Health
A Phase 3 study, sponsored by University of Delaware.
- Completed
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
NCT02941718 is a Phase 3 study that has completed, run by University of Delaware. The registered enrollment target is 30 participants.
The verdict
NCT02941718, a Phase 3 study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
Study Summary
Most treatment-seeking smokers will fail in their attempts to quit smoking in the early days and weeks of quitting. Poor sleep (e.g., short duration) is an overlooked, but important nicotine withdrawal symptom that can affect up to 80% of treatment seeking smokers and predicts relapse. Addressing sleep deficits could promote cessation, particularly in smokers who may be vulnerable to poor sleep in one or more sleep metrics even before quitting. This study will address this conceptual and empirical gap by conducting a 15-week proof-of-concept study to determine whether standard smoking cessation treatment can be optimized with a multi-metric sleep advancement counseling intervention.
Interventions
- BEHAVIORAL General Health Information
- BEHAVIORAL Sleep Advancement Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-11-01 |
| Est. Completion | 2019-01-17 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02941718
The ClinicalTrials.gov registry entry for NCT02941718 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which General Health Information is the first listed.
NCT02941718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02941718 about?
NCT02941718 is a clinical study titled "Examination of Sleep, Smoking Cessation, and Cardiovascular Health". Most treatment-seeking smokers will fail in their attempts to quit smoking in the early days and weeks of quitting. Poor sleep (e.g., short duration) is an overlooked, but important nicotine withdrawal symptom that can affect up to 80% of treatment seeking smokers and predicts relapse. Addressing sl...
What is the current status of trial NCT02941718?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2016-11-01. Estimated completion is 2019-01-17.
What interventions are being tested in trial NCT02941718?
The interventions under investigation include: General Health Information (BEHAVIORAL), Sleep Advancement Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02941718?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.